Bacterial magnetic particles as a novel and efficient gene vaccine delivery system

51Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA vaccination is an attractive approach for eliciting antigen-specific immunity. In this study, we used magnetosomes (bacterial magnetic particles, BMPs) as carriers of a recombinant DNA composed of a secondary lymphoid tissue chemokine, human papillomavirus type E7 (HPV-E7) and Ig-Fc fragment (pSLC-E7-Fc) to generate a gene vaccine (BMP-V) for tumour immunotherapy. The results indicate that BMPs linked to DNA more efficiently in phosphate-buffered saline (pH4-5) than in physiological saline. Efficient transfection of BMP-V in vitro and in vivo was achieved when a 600-mT static magnetic field was applied for 10 min. In a mouse tumour model, subcutaneous injection of BMP-V (5 μg, × 3 at 4-day intervals) plus magnetic exposure elicited systemic HPV-E7-specific immunity leading to significant tumour inhibition. The treated mice tolerated BMP-V immunisation well with no toxic side effects, as shown by histopathological examinations of major internal organs. Taken together, these results suggest that BMP can be used as a gene carrier to elicit a systemic immune response. © 2012 Macmillan Publishers Limited.

Cite

CITATION STYLE

APA

Tang, Y. S., Wang, D., Zhou, C., Ma, W., Zhang, Y. Q., Liu, B., & Zhang, S. (2012). Bacterial magnetic particles as a novel and efficient gene vaccine delivery system. Gene Therapy, 19(12), 1187–1195. https://doi.org/10.1038/gt.2011.197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free